Hang Hu

6PUBLICATIONS
1CO-AUTHORS
GlycoconjugatesCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 26, 2024
Reduction-Responsive RGD-Docetaxel Conjugate: Synthesis, In Vitro Drug Release and In Vitro Antitumor Activity.

Qingqing Li, Yufeng Liu, Yilin Cheng

|Jul 11, 2024
Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy.

Jiangfei Liu, Yaohui Ni, Keyun Zhou

|Mar 20, 2024
Synthesis and in vitro antitumor activity of galactosamine-docetaxel conjugates.

Yongpeng Shen, Yilin Cheng, Haotian Hu

|Mar 05, 2024
Biotin-new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution.

Shengping Liu, Fang Ding, Wei Xu

|Nov 03, 2021
A comparative study of the in vitro antitumor effect of mannose-doxorubicin conjugates with different linkers.

Xinxin Cui, Kunda Du, Xiaoyin Yuan

Pageof 1

Frequent Collaborators